產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
- 400-999-210024小時(shí)服務(wù)熱線
UM-UC-3 (人膀胱移行細(xì)胞癌) (STR鑒定正確)
貨號(hào):CL-0463
規(guī)格:1×10?cells/T25培養(yǎng)瓶
價(jià)格: ¥1600
生長(zhǎng)培養(yǎng)基:MEM(含NEAA)+10% FBS+1% P/S
推薦搭配
套餐1:
細(xì)胞培養(yǎng)最優(yōu)解!
套餐組合價(jià):¥1950¥2050
搭配套餐已成功加入購(gòu)物車!
產(chǎn)品概述
名稱 | UM-UC-3 (人膀胱移行細(xì)胞癌) (STR鑒定正確) |
別稱 | UMUC-3; UM-UC3; UMUC3; UC-3; University of Michigan-Urothelial Carcinoma-3 |
種屬 | 人 |
生長(zhǎng)特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
生長(zhǎng)培養(yǎng)基:
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:3-1:4 |
推薦換液頻率 | 2-3次/周 |
年齡(性別) | 男性 |
組織來(lái)源 | 器官:膀胱;疾?。阂菩屑?xì)胞癌 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 膀胱癌細(xì)胞 |
生物安全等級(jí) | BSL-1 |
保藏機(jī)構(gòu) | ATCC; CRL-1749 ECACC; 96020936 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 10,11 D2S1338 23 D3S1358 17,18 D5S818 12 D7S820 8,9 D8S1179 13 D13S317 8 D16S539 8,9 D18S51 14 D19S433 14,15 D21S11 31 FGA 20,21 PentaD 13 PentaE 12 TH01 6,9 TPOX 10 vWA 17 D6S1043 11,13 D12S391 22 D2S441 11 -
STR鑒定圖
參考文獻(xiàn)
-
WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity(2023/01/07)
作者:Xiaosong Wei, Beibei Wang, Zixin Wu
期刊:CANCER LETTERS
DOI:10.1016/j.canlet.2023.216058
影響因子 :9.700
引用產(chǎn)品:CL-0002 CL-0125 CL-0222 CL-0227 CL-0463 CL-0628 PM150410 PM150710 PM150910 PM151010
-
Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential for personalized treatment(2024/01/05)
作者:Keqiang Li, Zhenlin Huang, Guoqing Xie
期刊:Journal of Translational Medicine
DOI:10.1186/s12967-023-04815-y
影響因子 :7.400
引用產(chǎn)品:CL-0463
-
MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI(2020/03/03)
作者:Xiaosong Wei, Beibei Wang, Qi Wang
期刊:Frontiers in Pharmacology
影響因子 :5.600
-
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis(2023/12/12)
作者:Zhouting Tuo, Dechao Feng, Zhiwei Jiang
期刊:Chinese Journal of Cancer Research
DOI:10.21147/j.issn.1000-9604.2023.06.12
影響因子 :5.100
引用產(chǎn)品:CL-0463
-
A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer(2024/02/08)
作者:Zhen Song, Shikai Gui, Shuaiyun Xiao
期刊:Scientific Reports
DOI:10.1038/s41598-024-53272-0
影響因子 :4.600
引用產(chǎn)品:CL-0463
-
Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis(2024/02/02)
作者:Han Wang, Junjie Liu, Yanyan Lou
期刊:Scientific Reports
DOI:10.1038/s41598-024-53265-z
影響因子 :4.600
引用產(chǎn)品:CL-0463
-
NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway( 2022/01/02)
作者:Bo Li, Qian Xiao, Liping Shan
期刊:Cell Cycle
DOI:10.1080/15384101.2021.2021050
影響因子 :4.300
-
TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer(2024/02/09)
作者:Runhua Tang, Haoran Wang, Jianyong Liu
期刊:EUROPEAN JOURNAL OF MEDICAL RESEARCH
DOI:10.1186/s40001-024-01688-9
影響因子 :4.200
引用產(chǎn)品:CL-0463
-
CENPW knockdown inhibits progression of bladder cancer through inducing cell cycle arrest and apoptosis(2024/01/01)
作者:Peng Zhang, Qian Yang, Xulong Chen
期刊:Journal of Cancer
影響因子 :3.900
引用產(chǎn)品:CL-0463
-
Nitidine chloride regulates cell function of bladder cancer in vitro through downregulating Lymphocyte antigen 75(2023/03/14)
作者:Shishuo Wang, Gaoqiang Zhai, Zhiguang Huang
期刊:NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
DOI:10.1007/s00210-023-02446-0
影響因子 :3.600
-
PC4 promotes bladder cancer progression and stemness by directly interacting with Sp1 to transcriptionally activate the Wnt5a/β-catenin pathway(2024/05/26)
作者:Benhuang Yan, Peng Luo, Heping Qiu
期刊:PATHOLOGY RESEARCH AND PRACTICE
影響因子 :2.800
引用產(chǎn)品:CL-0463
-
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation(2024/03/13)
作者:Rong Wang, Fei Xu, Zhengjia Yang
期刊:BMC Urology
DOI:10.1186/s12894-024-01444-5
影響因子 :2.000
引用產(chǎn)品:CL-0463
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料
識(shí)別碼示意圖